Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces

Delphine Lapaillerie, Cathy Charlier, Véronique Guyonnet-Dupérat, Emilie Murigneux, Henrique S. Fernandes, Fábio G. Martins, Rita P. Magalhães, Tatiana F. Vieira, Clémence Richetta, Frédéric Subra, Samuel Lebourgeois, Charlotte Charpentier, Diane Descamps, Benoît Visseaux, Pierre Weigel, Alexandre Favereaux, Claire Beauvineau, Frédéric Buron, Marie-Paule Teulade-Fichou, Sylvain Routier, Sarah Gallois-Montbrun, Laurent Meertens, Olivier Delelis, Sérgio F. Sousa, Vincent Parissi

Open source

DOI
10.1128/aac.00083-22
Published
2022-08-16
Container
Antimicrobial Agents and Chemotherapy
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/aac.00083-22,
  title = {Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces},
  author = {Delphine Lapaillerie and Cathy Charlier and Véronique Guyonnet-Dupérat and Emilie Murigneux and Henrique S. Fernandes and Fábio G. Martins and Rita P. Magalhães and Tatiana F. Vieira and Clémence Richetta and Frédéric Subra and Samuel Lebourgeois and Charlotte Charpentier and Diane Descamps and Benoît Visseaux and Pierre Weigel and Alexandre Favereaux and Claire Beauvineau and Frédéric Buron and Marie-Paule Teulade-Fichou and Sylvain Routier and Sarah Gallois-Montbrun and Laurent Meertens and Olivier Delelis and Sérgio F. Sousa and Vincent Parissi},
  year = {2022},
  journal = {Antimicrobial Agents and Chemotherapy},
  doi = {10.1128/aac.00083-22},
  url = {https://doi.org/10.1128/aac.00083-22}
}

RIS

TY  - JOUR
TI  - Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces
AU  - Delphine Lapaillerie
AU  - Cathy Charlier
AU  - Véronique Guyonnet-Dupérat
AU  - Emilie Murigneux
AU  - Henrique S. Fernandes
AU  - Fábio G. Martins
AU  - Rita P. Magalhães
AU  - Tatiana F. Vieira
AU  - Clémence Richetta
AU  - Frédéric Subra
AU  - Samuel Lebourgeois
AU  - Charlotte Charpentier
AU  - Diane Descamps
AU  - Benoît Visseaux
AU  - Pierre Weigel
AU  - Alexandre Favereaux
AU  - Claire Beauvineau
AU  - Frédéric Buron
AU  - Marie-Paule Teulade-Fichou
AU  - Sylvain Routier
AU  - Sarah Gallois-Montbrun
AU  - Laurent Meertens
AU  - Olivier Delelis
AU  - Sérgio F. Sousa
AU  - Vincent Parissi
PY  - 2022
JO  - Antimicrobial Agents and Chemotherapy
DO  - 10.1128/aac.00083-22
UR  - https://doi.org/10.1128/aac.00083-22
ER  - 

APA

Lapaillerie, D., Charlier, C., Guyonnet-Dupérat, V., Murigneux, E., Fernandes, H. S., Martins, F. G., Magalhães, R. P., Vieira, T. F., Richetta, C., Subra, F., Lebourgeois, S., Charpentier, C., Descamps, D., Visseaux, B., Weigel, P., Favereaux, A., Beauvineau, C., Buron, F., Teulade-Fichou, M., Routier, S., Gallois-Montbrun, S., Meertens, L., Delelis, O., Sousa, S. F., & Parissi, V. (2022). Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00083-22

Source records